Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -120.15 is 77% above its 5-year average of -533.30, near the high end of its 5-year range (-1062.90–-120.15).
48.59% above its 12-month average of -233.70.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -9.60.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
EARNINGS PER SHARE (EPS)
-120.15
EARNINGS PER SHARE (EPS) AVG TTM
-233.70
EARNINGS PER SHARE (EPS) AVG 3Y
-422.85
EARNINGS PER SHARE (EPS) AVG 5Y
-533.30
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+48.59%
CURRENT VS 3Y AVG
+71.59%
CURRENT VS 5Y AVG
+77.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
bioAffinity Technologies, Inc.
Market Cap
$2.59M
Earnings Per Share (EPS)
-120.15
TTM Avg
-233.70
3Y Avg
-422.85
5Y Avg
-533.30
Market Cap
$2.47M
Earnings Per Share (EPS)
-6.00
TTM Avg
-7.57
3Y Avg
-7.54
5Y Avg
-5.31
Market Cap
$2.37M
Earnings Per Share (EPS)
-2.00
TTM Avg
-3.12
3Y Avg
-4.82
5Y Avg
-95.40
Market Cap
$3.09M
Earnings Per Share (EPS)
-22.20
TTM Avg
-27.40
3Y Avg
-44.30
5Y Avg
-249.07
Market Cap
$3.13M
Earnings Per Share (EPS)
-1.43
TTM Avg
-2.52
3Y Avg
-2.09
5Y Avg
-1.32
Market Cap
$1.92M
Earnings Per Share (EPS)
-46.49
TTM Avg
-92.15
3Y Avg
-143.14
5Y Avg
-171.91
Market Cap
$3.37M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
Market Cap
$3.44M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
Market Cap
$3.48M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.59M | -120.15 | -233.70 | -422.85 | -533.30 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | -6.00 | -7.57 | -7.54 | -5.31 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | -2.00 | -3.12 | -4.82 | -95.40 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -22.20 | -27.40 | -44.30 | -249.07 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | -1.43 | -2.52 | -2.09 | -1.32 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | -46.49 | -92.15 | -143.14 | -171.91 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | -4.90 | -7.69 | -8.41 | -8.41 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | -11.70 | -48.19 | -238.41 | -340.02 |
| Evogene Ltd. (EVGN)vs › | $3.48M | -0.91 | -1.99 | -3.92 | -2.83 |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
Trailing EPS (TTM)
$-120.15
Forward EPS (Est.)
$-121.50
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -129.90 |
| 2024-12-31 | -337.50 |
| 2023-12-31 | -409.50 |
| 2022-12-31 | -814.50 |
| 2021-12-31 | -1062.90 |
| 2020-12-31 | -445.50 |
| 2019-12-31 | -202.50 |
